A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study.
The purpose of this pilot study was to examine the effect of a structured smoking cessation intervention during hospitalization on short-term smoking abstinence. Hospitalized surgical oncology patients who smoked (n = 26) and were diagnosed with cancer were randomly assigned to either an experimental or control group. Experimental group subjects (n = 12) received a structured smoking cessation intervention during hospitalization followed by five weekly phone calls after discharge. Control group subjects (n = 14) received usual care from their health-care providers during hospitalization. Abstinence from smoking, as determined by saliva cotinine, the primary metabolite of nicotine, was measured at first postdischarge visit. Subjects with a saliva cotinine level of < 10 ng/ml were classified as abstinent. At first postdischarge visit, 75% of experimental group subjects were abstinent compared with 42.9% in the usual care group, a 32% difference. These preliminary findings will assist in the design and further evaluation of cancer rehabilitation strategies promoting cessation in hospitalized postoperative cancer patients who continue to smoke.
Marymount Hospital, Garfield Heights, Ohio.
A E
AE
Stanislaw
M E
ME
Wewers
D000328:Adult; D000368:Aged; D003367:Cotinine / Q000032:analysis; D005260:Female; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000451:nursing / Q000601:surgery*; D010865:Pilot Projects; D012463:Saliva / Q000737:chemistry; D012907:Smoking / Q000378:metabolism; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention
D003367:Cotinine